Ignite Creation Date:
2024-05-06 @ 6:10 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05563558
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2022-09-21
Brief Title:
Pembrolizumab Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer PEAPOD_FOS
Sponsor:
Fundacion Oncosur
Organization:
Fundacion Oncosur
Organization Data
Organization:
Fundacion Oncosur
Class:
NETWORK
Study ID:
PEAPOD_FOS042022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fundacion Oncosur
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None